India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
16/09/2026 08:18
BUZZ-India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility ** Shares of Aurobindo Pharma ARBN.NS fall as much as 2.2% to 1,623 rupees; last down 1.4%
** U.S. FDA inspection of manufacturing facility of co's wholly owned subsidiary Apitoria Pharma in southern state of Telangana resulted in one observation related to procedures and documentation, co says
** YTD, stock up about 38%
(Reporting by Anushka Rajvedi in Bengaluru)
((mailto: anushka.rajvedi@thomsonreuters.com))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11